Development of software that predicts the response of chemotherapy in colorectal and head and neck cancers through artificial intelligence

Intervention1: Blood and tissue sample collection: The study has been classified as interventional as we are collecting tissue and blood samples from the patients
Control Intervention1: NA: NA
Primary outcome(s): â?¢Improved understanding of the response of patients to cancer therapeutics based on their correlation to various factors.
â?¢Better ability to predict therapy response and match patients with the right treatment options compared to conventional approaches, in both CRC and HNSCC.
Timepoint: 18 months